Brief: Cantargia Says Can10 Shows Positive Activity In Systemic Sclerosis Models

Cantargia AB

09/11/2022 09:10

Nov 9 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA'S CAN10 DEMONSTRATES POSITIVE ACTIVITY IN
SYSTEMIC
SCLEROSIS MODELS IN NEW DATA PRESENTED AT ACR CONVERGENCE 2022
    * CAN10 REDUCED BOTH PATHOLOGICAL INFLAMMATION AND FIBROSIS
IN
SKIN AND LUNG TISSUE, FACTORS ASSOCIATED WITH CLINICAL SEVERITY
IN HUMANS
    * CAN10 ALSO NORMALIZED A NUMBER OF BIOMARKERS CLOSELY
ASSOCIATED
WITH HUMAN DISEASE

Source text for Eikon:  ID:nWkr3klgKJ 
Further company coverage:  CANTA.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))